Published Date: 02 Mar 2023
Researchers seek to predict markers of the state of obesity, the risk of associated complications and the response to diet or bariatric surgery.
Read Full News1.
Could CT scans be fueling a future rise in cancer cases, as a new study suggests?
2.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
3.
Optimizing Sequencing of BCMA-Directed Therapies in Myeloma
4.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
5.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
1.
Unravelling the Mysteries of Monoclonal Gammopathy
2.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
3.
Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer
4.
Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More
5.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
2.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation